Stop circulation of 7 types of drugs imported by VN Pharma company

These medications include: H2K 200, H2K 250, H2K 400, H2K500, H2K750, H-Cipox 200 and H-Levo 500.

The Drug Administration of Vietnam (Ministry of Health) has just decided to withdraw the registration numbers of 7 drug products imported by Vietnam Pharma company from a pharmaceutical company in Canada.

Seven types of drugs of Vietnam Pharma pharmaceutical company headquartered in Ward 14, District 10, Ho Chi Minh City have been discontinued from circulation, including: H2K 200, H2K 250, H2K 400, H2K500, H2K750, H-Cipox 200 and H-Levo 500.

The 7 drugs that have been discontinued are all produced by Helix Pharmaceuticals in Canada and imported by VN Pharma (Illustration photo)

These drugs are all in the form of intravenous infusion solutions, containing the active ingredients Ciprofloxacin and Levofloxacin used to treat infections such as sinusitis, pneumonia, sepsis, etc.

These 7 drugs are all manufactured by Helix Pharmaceuticals in Canada and imported by VN Pharma. The registration of these 7 drugs was withdrawn from the list of drugs circulated in Vietnam because the drug information data files were not consistent with the actual production.

Along with stopping the circulation of the above drugs, the Drug Administration also decided to stop receiving first-time registration applications, re-registration applications and not issue drug circulation registration numbers for submitted applications registered by Vietnam Pharma Company and produced by Helix Pharmaceuticals Company.

Recently, the Ho Chi Minh City Department of Health also canceled the bidding results of 7 drug products that won the bid in May 2014, including 2 drug products of Vietnam Pharma and its member company, Nam Anh Pharmaceutical, that won the bid./.

According to VOV.VN